Literature DB >> 3167945

Cardiovascular effects of leukotoxin (9, 10-epoxy-12-octadecenoate) and free fatty acids in dogs.

A Fukushima1, M Hayakawa, S Sugiyama, M Ajioka, T Ito, T Satake, T Ozawa.   

Abstract

Leukotoxin (9,10-epoxy-12-octadecenoate) biosynthesised from linoleate by neutrophils is highly toxic to cellular function. Its cardiovascular effects were studied in dogs together with the effects of various fatty acids. Aortic flow, left ventricular peak dP.dt-1, and aortic pressure were measured in 60 anaesthetised dogs, which were divided into 10 groups of six animals each--namely, control group (10 ml of physiological saline), three leukotoxin groups (5, 10, and 50 mg.kg-1), two linoleic acid groups (10 and 50 mg.kg-1), two oleic acid groups (10 and 50 mg.kg-1), and two stearic acid groups (10 and 50 mg.kg-1). Leukotoxin injected intravenously depressed cardiac function in a dose dependent manner. Administration of leukotoxin 5 mg.kg-1 showed no significant cardiotoxic effect. However, 10 mg.kg-1 of leukotoxin significantly decreased aortic flow from 0.74(0.04) to 0.40(0.07) litre.min-1 (mean(SEM], left ventricular peak dP.dt-1 from 2040(205) to 1140(217) mmHg.s-1, and aortic pressure from 106(7.1)/67(6.3) to 75(9.2)/48(6.5) mmHg 5 min after injection. Dogs given leukotoxin 50 mg.kg-1 showed more pronounced cardiodepressive effects; aortic flow was decreased to 0.19(0.06), left ventricular dP.dt-1 to 560(134), and aortic pressure to 72(15.1)/41(10.6) 5 min after injection. All dogs in this group were dead within 45 min. Administration of 10 mg.kg-1 of linoleic acid, oleic acid, or stearic acid caused no significant haemodynamic changes. Administration of linoleic acid 50 mg.kg-1 had cardiotoxic effects, but the effect was less than that of leukotoxin. Since leukotoxin appears to be a potent cardiodepressive agent it may be an important factor in the development of heart failure observed in patients with severe burns.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3167945     DOI: 10.1093/cvr/22.3.213

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  13 in total

Review 1.  Cytochrome P450-derived linoleic acid metabolites EpOMEs and DiHOMEs: a review of recent studies.

Authors:  Kelsey Hildreth; Sean D Kodani; Bruce D Hammock; Ling Zhao
Journal:  J Nutr Biochem       Date:  2020-08-20       Impact factor: 6.048

2.  Potent urea and carbamate inhibitors of soluble epoxide hydrolases.

Authors:  C Morisseau; M H Goodrow; D Dowdy; J Zheng; J F Greene; J R Sanborn; B D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

3.  Metabolomics reveals increased isoleukotoxin diol (12,13-DHOME) in human plasma after acute Intralipid infusion.

Authors:  Lindsay M Edwards; Nathan G Lawler; Sonja B Nikolic; James M Peters; James Horne; Richard Wilson; Noel W Davies; James E Sharman
Journal:  J Lipid Res       Date:  2012-06-19       Impact factor: 5.922

4.  Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart.

Authors:  Matthew L Edin; Zhongjing Wang; J Alyce Bradbury; Joan P Graves; Fred B Lih; Laura M DeGraff; Julie F Foley; Robert Torphy; Oline K Ronnekleiv; Kenneth B Tomer; Craig R Lee; Darryl C Zeldin
Journal:  FASEB J       Date:  2011-06-22       Impact factor: 5.191

5.  Effects of high-fat diet on plasma profiles of eicosanoid metabolites in mice.

Authors:  Weicang Wang; Jun Yang; Haixia Yang; Katherine Z Sanidad; Bruce D Hammock; Daeyoung Kim; Guodong Zhang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2016-11-30       Impact factor: 3.072

6.  Immunohistochemical dynamics of leukotoxin (9,10-epoxy-12-octadecenoic acid) in lungs of rats.

Authors:  W Zhang; M Nagao; T Takatori; K Iwadate; Y Itakura; Y Yamada; H Iwase; T Oono
Journal:  Int J Legal Med       Date:  1995       Impact factor: 2.686

7.  Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model.

Authors:  Arzu Ulu; Benjamin B Davis; Hsing-Ju Tsai; In-Hae Kim; Christophe Morisseau; Bora Inceoglu; Oliver Fiehn; Bruce D Hammock; Robert H Weiss
Journal:  J Cardiovasc Pharmacol       Date:  2008-10       Impact factor: 3.105

8.  Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice.

Authors:  Ketul R Chaudhary; Beshay N M Zordoky; Matthew L Edin; Nasser Alsaleh; Ayman O S El-Kadi; Darryl C Zeldin; John M Seubert
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-08-16       Impact factor: 3.072

9.  Leukotoxin, a linoleate epoxide: its implication in the late death of patients with extensive burns.

Authors:  K Kosaka; K Suzuki; M Hayakawa; S Sugiyama; T Ozawa
Journal:  Mol Cell Biochem       Date:  1994-10-26       Impact factor: 3.396

10.  Effects of hemodialysis on plasma oxylipins.

Authors:  Benjamin Gollasch; Guanlin Wu; Inci Dogan; Michael Rothe; Maik Gollasch; Friedrich C Luft
Journal:  Physiol Rep       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.